dr. timothy hughes compares imatinib to nilotinib in chronic myeloid leukemia
Published 11 years ago • 1.5K plays • Length 1:40Download video MP4
Download video MP3
Similar videos
-
9:48
chronic myeloid leukaemia (cml) with professor tim hughes
-
58:32
world cml day webinar with professor tim hughes
-
5:49
tidel-ii: switching from imatinib to nilotinib in cml
-
1:26
the efficacy of nilotinib treatment approaches in frontline cml
-
9:48
talking chronic myeloid leukaemia (cml) with professor tim hughes
-
1:27
timothy hughes - chronic myeloid leukaemia (cml) news
-
8:12
treatment selection for resistant or intolerant chronic myeloid leukemia
-
2:10
timothy hughes - chronic myeloid leukaemia (cml) news
-
4:47
nilotinib versus imatinib in patients with newly diagnosed philadelphia chromosome-positive cml-cp
-
1:28
dr giuseppe saglio compares efficacy, safety of nilotinib with imatinib for cml patients
-
2:53
comparing bosutinib versus imatinib in newly diagnosed cml
-
1:59
comparing frontline therapies for the treatment of chronic myeloid leukemia
-
3:04
nilotinib for myeloid leukemia
-
1:43
dr. hochhaus on tfs with nilotinib in patients with cml
-
2:10
the importance of achieving early molecular response in cml
-
1:50
dr. donnellan on tfr in patients with cml treated with nilotinib
-
3:54
summary of cardiac effects of nilotinib and imatinib in patients enrolled in enestnd trial
-
6:41
tfr with nilotinib in cml: enestfreedom and enestop
-
2:12
5-year update of bfore: bosutinib vs imatinib in cml